Cabot (NYSE:CBT – Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Monday, November 4th. Analysts expect the company to announce earnings of $1.82 per share for the quarter. Cabot has set its FY24 guidance at $7.00-$7.10 EPS.Parties interested in participating in the company’s conference call can do so using this link.
Cabot (NYSE:CBT – Get Free Report) last released its earnings results on Monday, August 5th. The specialty chemicals company reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. Cabot had a net margin of 12.05% and a return on equity of 26.99%. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1 billion. During the same period in the prior year, the firm earned $1.42 EPS. The company’s revenue was up 5.0% compared to the same quarter last year. On average, analysts expect Cabot to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.
Cabot Price Performance
Cabot stock opened at $109.26 on Monday. The company has a current ratio of 2.22, a quick ratio of 1.45 and a debt-to-equity ratio of 0.72. The business’s 50 day simple moving average is $107.40 and its 200 day simple moving average is $100.31. Cabot has a 12 month low of $65.10 and a 12 month high of $117.14. The company has a market cap of $6.04 billion, a price-to-earnings ratio of 13.83, a PEG ratio of 0.93 and a beta of 1.19.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Analysis on CBT
Insider Activity
In other Cabot news, CFO Erica Mclaughlin sold 23,274 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $99.79, for a total value of $2,322,512.46. Following the completion of the transaction, the chief financial officer now owns 59,814 shares in the company, valued at $5,968,839.06. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CFO Erica Mclaughlin sold 23,274 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total transaction of $2,322,512.46. Following the sale, the chief financial officer now owns 59,814 shares of the company’s stock, valued at approximately $5,968,839.06. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Jeff Ji Zhu sold 1,201 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $106.19, for a total transaction of $127,534.19. Following the completion of the transaction, the executive vice president now directly owns 96,000 shares of the company’s stock, valued at approximately $10,194,240. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 71,939 shares of company stock worth $7,308,812. 3.07% of the stock is owned by corporate insiders.
Cabot Company Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Stories
- Five stocks we like better than Cabot
- Consumer Discretionary Stocks Explained
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.